Certolizumab Pegol in the Treatment of Patients with Moderate to Severe Chronic Plaque-Psoriasis: An Overview of 3 Randomized, Controlled Clinical Studies
Author Type(s)
Faculty
Document Type
Abstract
Publication Date
3-2018
Journal Title
The Journal der Deutschen Dermatologischen Gesellschaft
Department
Dermatology
Recommended Citation
Lendl, U., Blauvelt, A., Reich, K., Lebwohl, M., Burge, D., Arendt, C., Peterson, L., Drew, J., Rolleri, R., & Gottlieb, A. (2018). Certolizumab Pegol in the Treatment of Patients with Moderate to Severe Chronic Plaque-Psoriasis: An Overview of 3 Randomized, Controlled Clinical Studies. The Journal der Deutschen Dermatologischen Gesellschaft, 16 (Suppl. 1), 15-16. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/388
COinS
